Cargando…
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems
MICRO ABSTRACT: Targeted intraoperative radiotherapy (TARGIT-IORT) is delivered immediately after lumpectomy for breast cancer. We estimated its impact. At least 44,752 patients with breast cancer were treated with TARGIT-IORT in 260 centres in 35 countries, saving >20 million miles of travel and...
Autores principales: | Vaidya, Jayant Sharad, Vaidya, Uma Jayant, Baum, Michael, Bulsara, Max Kishor, Joseph, David, Tobias, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406153/ https://www.ncbi.nlm.nih.gov/pubmed/36033486 http://dx.doi.org/10.3389/fonc.2022.786515 |
Ejemplares similares
-
Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom
por: Vaidya, Anil, et al.
Publicado: (2017) -
Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT
por: Coombs, Nathan J, et al.
Publicado: (2016) -
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
por: Vaidya, Jayant S, et al.
Publicado: (2020) -
TARGIT: an international trial of intraoperative versus external beam radiotherapy
por: Baum, M, et al.
Publicado: (2008) -
Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment
por: Vaidya, Jayant S., et al.
Publicado: (2021)